Aspirin prophylaxis and the prevalence of anaemia | Zendy

Robert HammermanRozenberg | Zendy; Jeremy M. Jacobs | Zendy; Daniel Azoulay | Zendy; Jochanan Stessman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aspirin prophylaxis and the prevalence of anaemia

Author(s) -

Robert HammermanRozenberg,

Jeremy M. Jacobs,

Daniel Azoulay,

Jochanan Stessman

Publication year - 2006

Publication title -

age and ageing

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.014

H-Index - 143

eISSN - 1468-2834

pISSN - 0002-0729

DOI - 10.1093/ageing/afl066

Subject(s) - medicine , aspirin , low dose aspirin , gastrointestinal bleeding , intensive care medicine , disease , gastroenterology

Anaemia and vascular disease are both common amongst the elderly and frequently co-exist. Whilst a consensus exists concerning the benefits of low-dose aspirin in reducing risk from atheromatous disease, nonetheless concerns arise in view of its harmful effect on gastric mucosa and its influence upon haemostasis, with the possibility of subsequent gastrointestinal bleeding. This study examined the relationship between chronic low-dose aspirin therapy and the presence of anaemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research